EP Wealth Advisors’s NEVRO CORP. NVRO Stock Holding History

EP Wealth Advisors’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,900	Closed	-$235K	–	670
2021 Q4	$235K	Buy	+2,900	New	+$291K	0.01%	507

Other funds holding NVRO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

EP Wealth Advisors's NVRO Position: Q1 2022 in Review

EP Wealth Advisors sold out of NEVRO CORP. (NVRO) in Q1 2022, closing a stake of 2,900 shares — an estimated $235K sold.

EP Wealth Advisors first reported a position in NVRO in Q4 2021 and held it in 1 quarter. The position peaked at $235K in Q4 2021. 195 funds tracked by Wall St. Rank hold NVRO as of Q1 2022.

EP Wealth Advisors reported no remaining NEVRO CORP. position as of Q1 2022 after selling out during the quarter.
EP Wealth Advisors sold 2,900 NEVRO CORP. shares in Q1 2022, an estimated $235K.
EP Wealth Advisors first reported a position in NEVRO CORP. in Q4 2021 and held it in 1 quarter.
EP Wealth Advisors's NEVRO CORP. position peaked at $235K in Q4 2021.
195 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2022.

Based on EP Wealth Advisors's 13F filing for Q1 2022, filed 20 May 2022.